Inside Africa’s drive to boost medicines and vaccine manufacturing Content provided by Last updated: 1 hour ago
With COVID-19 vaccine supplies to Africa slowing down, the continent is working to boost its own manufacturing capacities for vaccines, medicines and vital health technologies.
Mrs Biruk Abate Halallo, Health Attaché at Ethiopia’s Permanent Mission to the United Nations Offices in Geneva, is the driving force behind a resolution on the local manufacturing of medicines, medical technologies and vaccines that is being presented at the World Health Assembly, WHO’s leading decision-making body, this week.
What is the resolution for?
Africa suffers more than its fair share of communicable and non-communicable diseases. Over 90% of the world’s malaria deaths and 70% of all people living with HIV/AIDS are in Africa. More access to good medicines
Africa needs at least 20 million doses of AstraZenecaâs Covid-19 vaccine within the next six weeks, the World Health Organization said.
For the continent to vaccinate at least 10% of its population by September, another 200 million doses of any WHO Emergency Use listed Covid-19 vaccine is urgently needed.
The EU said it will send 100 million doses to low-income countries by the end of 2021 and the U.S. has pledged 80 million doses.
Africa needs at least 20 million doses of AstraZenecaâs Covid-19 vaccine within the next six weeks to get the second round of shots to people whoâve already received the first, the World Health Organization said.
Covid-19 vaccine apartheid : why local production must be strengthened swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.